Evaluation of acute and subacute toxicity of Abhrasindoora: As a mercury-based traditional herbo-bio-mineral metallic formulation

Q4 Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Sciences Asia Pub Date : 2023-01-01 DOI:10.29090/psa.2023.03.22.187
Rakesh Bramhankar, A. K. Mishra, Snigdha Das, N. Munishwar
{"title":"Evaluation of acute and subacute toxicity of Abhrasindoora: As a mercury-based traditional herbo-bio-mineral metallic formulation","authors":"Rakesh Bramhankar, A. K. Mishra, Snigdha Das, N. Munishwar","doi":"10.29090/psa.2023.03.22.187","DOIUrl":null,"url":null,"abstract":"Herbo-bio-mineral metallic preparations such as Abhrasindoora offer advantages over plant drugs under their stability over a period, lower dosage, and contain minerals and metals as an integral part of the formulations. The use of metals in medicine is often associated with toxicity. Present study was conducted to explore the acute and sub-acute toxicity study of Abhrasindoora in Wistar albino rats. Information related to possible health hazards, the estimate of no-observe-adverse-effect-level (NOAEL), hematology, and biochemical and histopathology parameters were studied. For the acute toxicity study rats were divided into two groups: Group I (Test group: 300 mg/kg) and Group II (Confirmatory group: 2,000 mg/kg) as per OECD 423 guidelines and for subacute toxicity study, rats were divided into four groups as Group I (water as the vehicle), Group II (600 mg/kg), Group III (800 mg/kg) and Group IV (1,000 mg/kg) as per OECD 407 guidelines. Clinical signs (daily); body weight and feed consumption (weekly) were taken. Blood samples were collected from the retro-orbital sinus before the necropsy (29 th day). For statistical analysis, one-way ANOVA and Dunnett’s test were used. In comparison to the control group, no mortality or adverse effects were observed. No significant variations were observed in hematological and biochemical parameters. In target organs, no significant changes were observed in both acute and sub-acute toxicity studies. No deaths or any signs of toxicity were observed after oral administration in the acute toxicity study up to the dose of 2,000 mg/kg and in the sub-acute toxicity study up to the dose of 1,000 mg/kg.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"86 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2023.03.22.187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Herbo-bio-mineral metallic preparations such as Abhrasindoora offer advantages over plant drugs under their stability over a period, lower dosage, and contain minerals and metals as an integral part of the formulations. The use of metals in medicine is often associated with toxicity. Present study was conducted to explore the acute and sub-acute toxicity study of Abhrasindoora in Wistar albino rats. Information related to possible health hazards, the estimate of no-observe-adverse-effect-level (NOAEL), hematology, and biochemical and histopathology parameters were studied. For the acute toxicity study rats were divided into two groups: Group I (Test group: 300 mg/kg) and Group II (Confirmatory group: 2,000 mg/kg) as per OECD 423 guidelines and for subacute toxicity study, rats were divided into four groups as Group I (water as the vehicle), Group II (600 mg/kg), Group III (800 mg/kg) and Group IV (1,000 mg/kg) as per OECD 407 guidelines. Clinical signs (daily); body weight and feed consumption (weekly) were taken. Blood samples were collected from the retro-orbital sinus before the necropsy (29 th day). For statistical analysis, one-way ANOVA and Dunnett’s test were used. In comparison to the control group, no mortality or adverse effects were observed. No significant variations were observed in hematological and biochemical parameters. In target organs, no significant changes were observed in both acute and sub-acute toxicity studies. No deaths or any signs of toxicity were observed after oral administration in the acute toxicity study up to the dose of 2,000 mg/kg and in the sub-acute toxicity study up to the dose of 1,000 mg/kg.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
艾布兰的急性和亚急性毒性评价:作为一种基于汞的传统草药-生物矿物金属制剂
草药生物矿物金属制剂,如Abhrasindoora,在一段时间内的稳定性,较低的剂量,以及含有矿物质和金属作为配方的组成部分,比植物药物具有优势。金属在医学中的使用常与毒性联系在一起。本研究探讨了阿布拉西多对Wistar白化大鼠的急性和亚急性毒性研究。研究了与可能的健康危害、无观察不良反应水平(NOAEL)估计、血液学、生化和组织病理学参数相关的信息。根据OECD 423指南,将急性毒性研究大鼠分为两组:ⅰ组(试验组:300 mg/kg)和ⅱ组(验证组:2000 mg/kg);亚急性毒性研究大鼠分为四组,即ⅰ组(水为载药)、ⅱ组(600 mg/kg)、ⅲ组(800 mg/kg)和ⅳ组(1000 mg/kg),按照OECD 407指南。临床症状(每日);测定体重和采食量(每周)。尸检前(第29天)取眶后窦血样。统计分析采用单因素方差分析和Dunnett检验。与对照组相比,没有观察到死亡率或不良反应。血液学和生化指标未见明显变化。在靶器官中,急性和亚急性毒性研究均未观察到显著变化。在剂量不超过2,000 mg/kg的急性毒性研究和剂量不超过1,000 mg/kg的亚急性毒性研究中,口服给药后未观察到死亡或任何毒性迹象。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmaceutical Sciences Asia
Pharmaceutical Sciences Asia Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍: The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.
期刊最新文献
Locally-isolated protease-producing Bacillus spp. from soil inhibits biofilm formation of Staphylococcus aureus Medication errors analysis in Asia and Australia: A systematic review The effect of different sweeteners on the free radical scavenging activities, alcohol contents, sugar reductions, and hedonic properties of green tea kombucha Development and validation of a GC-MS method for determination of amphetamine-type stimulants and ketamine in human hair Effect of zonisamide and Nigella sativa on blood-brain barrier permeability and neurological severity in traumatic brain injury-induced mice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1